As-Needed Budesonide/Formoterol Similar to Maintenance Budesonide Plus SABA in Patients with Mild Asthma

被引:0
|
作者
Ebell, Mark H. [1 ]
机构
[1] Univ Georgia, Athens, GA 30602 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:646 / 647
页数:2
相关论文
共 50 条
  • [31] Cost-effectiveness of as-needed budesonide-formoterol versus over-the-counter as-needed inhaled epinephrine in adults with mild asthma in the US
    Ho, Joseph
    Shaker, Marcus
    Greenhawt, Matthew
    Sadatsafavi, Mohsen
    Abrams, Elissa
    Oppenheimer, John
    Johnson, Kate
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB229 - AB229
  • [32] Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:: an efficacy and cost-effectiveness study
    Lundborg, Mikael
    Wille, Soren
    Bjermer, Leif
    Tilling, Bjorn
    Lundgren, Michael
    Telg, Gunilla
    Ekstrom, Tommy
    Selroos, Olof
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (05) : 809 - 821
  • [33] NUMBER NEEDED TO TREAT WITH AS-NEEDED BUDESONIDE/FORMOTEROL OR BUDESONIDE MAINTENANCE TO HAVE AN ADDITIONAL PATIENT FREE FROM A SEVERE OR MODERATE/SEVERE EXACERBATION: POST-HOC ANALYSIS OF SYGMA 1 IN MILD ASTHMA
    Reddel, H.
    O'Byrne, P.
    Bateman, D. E.
    Barnes, P.
    Zheng, J.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    Fitzgerald, J.
    RESPIROLOGY, 2020, 25 : 106 - 106
  • [34] NNT TO PREVENT ONE EXACERBATION WITH AS-NEEDED BUDESONIDE-FORMOTEROL
    Reddel, H.
    O'Byrne, P.
    Bateman, E.
    Barnes, P.
    Zheng, J.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    Fitzgerald, J.
    RESPIROLOGY, 2021, 26 : 81 - 81
  • [35] Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Sadatsafavi, Mohsen
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [36] THE COST-CONSEQUENCE OF BUDESONIDE/FORMOTEROL PLUS AS-NEEDED SABA AS TREATMENT FOR 6-12 YEARS OLD PEDIATRIC ASTHMA PATIENTS IN CHINABASED ON REAL-WORLD DATA
    Zuo, C.
    Jiang, Y.
    Zhou, K.
    Xie, X.
    Xuan, J.
    VALUE IN HEALTH, 2024, 27 (06) : S103 - S104
  • [37] Positioning As-needed Budesonide-Formoterol for Mild Asthma Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
    Bateman, Eric D.
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Barnes, Peter J.
    Zheng, Jinping
    Lamarca, Rosa
    Puu, Margareta
    Parikh, Himanshu
    Alagappan, Vijay
    Reddel, Helen K.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (12) : 2007 - 2017
  • [38] AS-NEEDED BUDESONIDE/FORMOTEROL FOR ADOLESCENTS WAS SUPERIOR TO AS-NEEDED TERBUTALINE AND COMPARABLE TO BUDESONIDE MAINTENANCE FOR SEVERE EXACERBATION RISK REDUCTION: POOLED SUBGROUP ANALYSIS OF THE SYGMA 1 AND 2 TRIALS
    Reddel, H.
    Bateman, E.
    Fitzgerald, J.
    Barnes, P.
    Zheng, J.
    Ivanov, S.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    O'Byrne, P.
    RESPIROLOGY, 2020, 25 : 97 - 97
  • [39] THE COST-EFFECTIVENESS OF BUDESONIDE/ FORMOTEROL MAINTENANCE AND RELIEVER THERAPY VERSUS SALMETEROL/FLUTICASONE PLUS AS-NEEDED SALBUTAMOL AMONG ASTHMA PATIENTS ≥12 YEARS IN CHINA
    Zhou, K.
    Xie, X.
    Zuo, C.
    Jiang, Y.
    Xuan, J.
    VALUE IN HEALTH, 2023, 26 (12) : S160 - S160
  • [40] Budesonide Formoterol as a Reliever Medication for Mild Asthma
    Krome, Susanne
    PNEUMOLOGIE, 2020, 74 (02): : 68 - 68